Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H28ClNO.ClH |
| Molecular Weight | 346.335 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN(CC)CCOC1(CCCCC1)C2=CC=C(Cl)C=C2
InChI
InChIKey=GHTNEJJXVUMOPX-UHFFFAOYSA-N
InChI=1S/C18H28ClNO.ClH/c1-3-20(4-2)14-15-21-18(12-6-5-7-13-18)16-8-10-17(19)11-9-16;/h8-11H,3-7,12-15H2,1-2H3;1H
Clofenciclan is a dopamine-releasing agent, developed by Boehringer & Soehne in the 1950s for the treatment of Parkinson's disease. Compared to other anti-parkinsonian drugs of the time, clofenciclan lacked peripheral anticholinergic properties and caused pronounced stimulation of the central nervous system.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID80928172
Created by
admin on Mon Mar 31 18:48:52 GMT 2025 , Edited by admin on Mon Mar 31 18:48:52 GMT 2025
|
PRIMARY | |||
|
25903
Created by
admin on Mon Mar 31 18:48:52 GMT 2025 , Edited by admin on Mon Mar 31 18:48:52 GMT 2025
|
PRIMARY | |||
|
SUB01355MIG
Created by
admin on Mon Mar 31 18:48:52 GMT 2025 , Edited by admin on Mon Mar 31 18:48:52 GMT 2025
|
PRIMARY | |||
|
8FR9OY53P6
Created by
admin on Mon Mar 31 18:48:52 GMT 2025 , Edited by admin on Mon Mar 31 18:48:52 GMT 2025
|
PRIMARY | |||
|
236-403-5
Created by
admin on Mon Mar 31 18:48:52 GMT 2025 , Edited by admin on Mon Mar 31 18:48:52 GMT 2025
|
PRIMARY | |||
|
100000087951
Created by
admin on Mon Mar 31 18:48:52 GMT 2025 , Edited by admin on Mon Mar 31 18:48:52 GMT 2025
|
PRIMARY | |||
|
13352-70-0
Created by
admin on Mon Mar 31 18:48:52 GMT 2025 , Edited by admin on Mon Mar 31 18:48:52 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
